Antibiotics for 3rd and 4th Degree Vaginal Lacerations, Uterine Tamponade, and Manual Placental Extraction
25 September 2019
03 October 2019
22 November 2019 (online)
Objective Trends in use of antibiotics during delivery hospitalizations complicated by (1) 3rd/4th degree vaginal lacerations, (2) manual placenta extraction, and (3) uterine tamponade are not well characterized. The objective of this study was to analyze trends in antibiotic use during vaginal delivery hospitalizations complicated by these three clinical scenarios.
Study Design An administrative inpatient database was used to perform a serial cross-sectional analysis of antibiotic administration during delivery hospitalizations in the United States from January 2006 to March 2015. The primary outcome was receipt of antibiotics during vaginal delivery hospitalizations complicated by (1) 3rd and 4th degree vaginal lacerations, (2) manual placenta extraction, and (3) uterine tamponade. Patients with other indications for antibiotics were excluded. The Cochran–Armitage test was used to assess trends. Adjusted log linear regression analyses including demographic, hospital, and obstetric factors were performed to analyze factors associated with antibiotic receipt for each of these three clinical scenarios in both primary and sensitivity analyses.
Results From 2006 to 2015 the rate of antibiotic administration during delivery hospitalizations decreased from 43.1% in 2006 to 25.5% for 3rd and 4th degree lacerations and from 59.6% to 49.2% for manual extraction (p < 0.01). Administration of antibiotics in the setting of uterine tamponade decreased from 48.6% in 2006 to 27.6% in 2009 before rising to 62.5% in the first quarter of 2015. In adjusted analyses, comparing the first quarter of 2015 to 2006 adjusted risk ratios for antibiotic administration were 0.61 (95% confidence interval [CI] 0.56–0.66) for 3rd and 4th degree vaginal lacerations, 0.76 (95% CI 0.53–1.09) for manual placental extraction, and 0.83 (95% CI 0.76–0.92) for uterine tamponade.
Conclusion Antibiotics are not used consistently during vaginal deliveries complicated by 3rd/4th degree lacerations, manual placenta extraction, and uterine tamponade. These findings support that a significant opportunity exists for comparative effectiveness research to assist in characterizing best practices.
This study was presented at the 39th Annual Meeting for the Society for Maternal Fetal Medicine, February, 2019, Las Vegas, Nevada.
- 1 Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003; 101 (01) 178-193
- 2 Tuuli MG, Liu J, Stout MJ. , et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 2016; 374 (07) 647-655
- 3 American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2011; 117 (04) 1019-1027
- 4 Verani JR, McGee L, Schrag SJ. ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59 (RR-10): 1-36
- 5 Van Dyke MK, Phares CR, Lynfield R. , et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360 (25) 2626-2636
- 6 Lukacs SL, Schrag SJ. Clinical sepsis in neonates and young infants, United States, 1988-2006. J Pediatr 2012; 160 (06) 960-5.e1
- 7 Smaill FM, Gyte GM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2010; (01) CD007482
- 8 Mercer BM, Miodovnik M, Thurnau GR. , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. JAMA 1997; 278 (12) 989-995
- 9 Chapman E, Reveiz L, Illanes E, Bonfill Cosp X. Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev 2014; (12) CD010976
- 10 Duggal N, Mercado C, Daniels K, Bujor A, Caughey AB, El-Sayed YY. Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. Obstet Gynecol 2008; 111 (06) 1268-1273
- 11 Coleman JMA, Silverman NS. ; Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstet Gynecol 2018; 132 (03) e103-e119
- 12 The World Health Organization. WHO guidelines for the management of postpartum hemorrhage and retained placenta. 2009. Available at: https://apps.who.int/iris/handle/10665/44171 . Accessed November 14, 2019
- 13 Wong MSDG, Dellapiana G, Greene N, Gregory KD. Antibiotics during intrauterine balloon tamponade is associated with a reduction in endometritis. Am J Perinatol 2019; 36 (12) 1211-1215
- 14 Franklin-Dumont THH, Kole M, Hillman J, Kieserman-Shmokler C, Sehdev H, Ludmir J. Use of Bakri balloon for postpartum hemorrhage as a risk factor for postpartum endometritis and sepsis. Am J Obstet Gynecol 2013; 208: 238-239
- 15 Lasley DSEA, Eblen A, Yancey MK, Duff P. The effect of placental removal method on the incidence of postcesarean infections. Am J Obstet Gynecol 1997; 176 (06) 1250-1254
- 16 Lewicky-Gaupp C, Leader-Cramer A, Johnson LL, Kenton K, Gossett DR. Wound complications after obstetric anal sphincter injuries. Obstet Gynecol 2015; 125 (05) 1088-1093
- 17 Fang MC, Maselli J, Lurie JD, Lindenauer PK, Pekow PS, Auerbach AD. Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. J Thromb Haemost 2011; 9 (07) 1318-1325
- 18 Kulik A, Rassen JA, Myers J. , et al. Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery. Circ Cardiovasc Interv 2012; 5 (04) 590-596
- 19 Prabhakaran S, Herbers P, Khoury J. , et al. Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?. Stroke 2015; 46 (02) 369-375
- 20 Ritch JM, Kim JH, Lewin SN. , et al. Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy. Obstet Gynecol 2011; 117 (06) 1367-1374
- 21 Wright JD, Lewin SN, Shah M. , et al. Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery. Ann Surg 2011; 253 (06) 1140-1146
- 22 Zacharia BE, Youngerman BE, Bruce SS. , et al. Quality of postoperative venous thromboembolism prophylaxis in neuro-oncologic surgery. Neurosurgery 2017; 80 (01) 73-81
- 23 Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010; 303 (24) 2479-2485
- 24 Kuklina EV, Whiteman MK, Hillis SD. , et al. An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J 2008; 12 (04) 469-477
- 25 US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK. , et al. Ocular prophylaxis for gonococcal ophthalmia neonatorum: US Preventive Services Task Force reaffirmation recommendation statement. JAMA 2019; 321 (04) 394-398